306: Successful phase II trial using mesenchymal stem cells (MSC) in combination with steroid therapy for the primary treatment of acute graft-vs-host disease (aGVHD)

✍ Scribed by P. Kebriaei; L. Isola; E. Bahceci; H.K. Holland; S. Rowley; J. McGuirk; M. Devetten; J. Jansen; R. Herzig; M. Schuster; J. Uberti

• Book ID: 116279486
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 60 KB
• Volume: 13
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2006.12.311